Non-invasive glioblastoma immunoprofiling by printed peptide arrays. Mock, A. & Herold-Mende, C. OncoImmunology, 5(2):e1069941, February, 2016. Number: 2Paper doi abstract bibtex Immune monitoring assays for patient stratification and treatment efficacy in clinical trials are in demand. We have recently described a cost-effective non-invasive assay to determine the immune status of glioblastoma patients. Profiling antitumor serum antibodies by customized printed peptide arrays identified response against a tenascin-C (TNC) peptide as a robust prognostic biomarker.
@article{mock_non-invasive_2016,
title = {Non-invasive glioblastoma immunoprofiling by printed peptide arrays},
volume = {5},
issn = {2162-402X},
url = {https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1069941},
doi = {10.1080/2162402X.2015.1069941},
abstract = {Immune monitoring assays for patient stratification and treatment efficacy in clinical trials are in demand. We have recently described a cost-effective non-invasive assay to determine the immune status of glioblastoma patients. Profiling antitumor serum antibodies by customized printed peptide arrays identified response against a tenascin-C (TNC) peptide as a robust prognostic biomarker.},
language = {en},
number = {2},
urldate = {2019-11-28},
journal = {OncoImmunology},
author = {Mock, Andreas and Herold-Mende, Christel},
month = feb,
year = {2016},
note = {Number: 2},
keywords = {Accessories, Application - Antibody Validation / Epitope Mapping, Application - Biomarker Discovery, Application - Cancer Research, Country - Germany, Human, PEPperCHIP - Customized - Linear, Sample Type - Plasma, Sample Type - Serum},
pages = {e1069941},
}
Downloads: 0
{"_id":"Lsyg6wahtqBtYoute","bibbaseid":"mock-heroldmende-noninvasiveglioblastomaimmunoprofilingbyprintedpeptidearrays-2016","authorIDs":[],"author_short":["Mock, A.","Herold-Mende, C."],"bibdata":{"bibtype":"article","type":"article","title":"Non-invasive glioblastoma immunoprofiling by printed peptide arrays","volume":"5","issn":"2162-402X","url":"https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1069941","doi":"10.1080/2162402X.2015.1069941","abstract":"Immune monitoring assays for patient stratification and treatment efficacy in clinical trials are in demand. We have recently described a cost-effective non-invasive assay to determine the immune status of glioblastoma patients. Profiling antitumor serum antibodies by customized printed peptide arrays identified response against a tenascin-C (TNC) peptide as a robust prognostic biomarker.","language":"en","number":"2","urldate":"2019-11-28","journal":"OncoImmunology","author":[{"propositions":[],"lastnames":["Mock"],"firstnames":["Andreas"],"suffixes":[]},{"propositions":[],"lastnames":["Herold-Mende"],"firstnames":["Christel"],"suffixes":[]}],"month":"February","year":"2016","note":"Number: 2","keywords":"Accessories, Application - Antibody Validation / Epitope Mapping, Application - Biomarker Discovery, Application - Cancer Research, Country - Germany, Human, PEPperCHIP - Customized - Linear, Sample Type - Plasma, Sample Type - Serum","pages":"e1069941","bibtex":"@article{mock_non-invasive_2016,\n\ttitle = {Non-invasive glioblastoma immunoprofiling by printed peptide arrays},\n\tvolume = {5},\n\tissn = {2162-402X},\n\turl = {https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1069941},\n\tdoi = {10.1080/2162402X.2015.1069941},\n\tabstract = {Immune monitoring assays for patient stratification and treatment efficacy in clinical trials are in demand. We have recently described a cost-effective non-invasive assay to determine the immune status of glioblastoma patients. Profiling antitumor serum antibodies by customized printed peptide arrays identified response against a tenascin-C (TNC) peptide as a robust prognostic biomarker.},\n\tlanguage = {en},\n\tnumber = {2},\n\turldate = {2019-11-28},\n\tjournal = {OncoImmunology},\n\tauthor = {Mock, Andreas and Herold-Mende, Christel},\n\tmonth = feb,\n\tyear = {2016},\n\tnote = {Number: 2},\n\tkeywords = {Accessories, Application - Antibody Validation / Epitope Mapping, Application - Biomarker Discovery, Application - Cancer Research, Country - Germany, Human, PEPperCHIP - Customized - Linear, Sample Type - Plasma, Sample Type - Serum},\n\tpages = {e1069941},\n}\n\n","author_short":["Mock, A.","Herold-Mende, C."],"key":"mock_non-invasive_2016","id":"mock_non-invasive_2016","bibbaseid":"mock-heroldmende-noninvasiveglioblastomaimmunoprofilingbyprintedpeptidearrays-2016","role":"author","urls":{"Paper":"https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1069941"},"keyword":["Accessories","Application - Antibody Validation / Epitope Mapping","Application - Biomarker Discovery","Application - Cancer Research","Country - Germany","Human","PEPperCHIP - Customized - Linear","Sample Type - Plasma","Sample Type - Serum"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/PEPperPAPER","creationDate":"2020-09-11T10:12:06.006Z","downloads":1,"keywords":["accessories","application - antibody validation / epitope mapping","application - biomarker discovery","application - cancer research","country - germany","human","pepperchip - customized - linear","sample type - plasma","sample type - serum"],"search_terms":["non","invasive","glioblastoma","immunoprofiling","printed","peptide","arrays","mock","herold-mende"],"title":"Non-invasive glioblastoma immunoprofiling by printed peptide arrays","year":2016,"dataSources":["uik5uKfH7ojkHRgZZ","SpW9DDZAb3MEcktZg","bsHtAr9WnaYGHaqfD","9uWGudyxZThtytFHj","pcAnmugzhzarwnP3W","aphoNEDcQuBnaRkJx","qiu7zqW2xcuf37WKP","RP5CxTRWvKp2zek6s","toHpjkGFdDM9JqudF","yiBnvepfTPGvjnmkb","xRJYNPtGuN7nnbwed","zQuC76ntAG5GnzpKd","vQydgodW2DnvbWLxr","bCft75h4ohnyjY7De","XfqicQ5BW2Zx785GB","BejHfCEEKKZLHTAiJ","iXPxmCb8iG4FtRXEa","9QJhBt6zEQqnhjyEQ","QsdwieyNM5tTaC5Xz","idrrfXaW5AQj5dNMY"]}